Implications of HER2 Amplification in Small, Node-Negative Breast Cancers: Do Asians Differ?

True Recurrence Versus New Primary: An Analysis of Ipsilateral Breast Tumor Recurrences After Breast-Conserving Therapy

(2011) Valerie Panet-Raymond et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

(2010) Melinda L. Telli et al.   BREAST CANCER RESEARCH AND TREATMENT

The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer

(2010) M. Toi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab Treatment in T1ab, Node-Negative, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Carcinomas

(2010) Manuel Jorge Rodrigues et al.   JOURNAL OF CLINICAL ONCOLOGY

Is Breast Cancer the Same Disease in Asian and Western Countries?

(2010) Stanley P. L. Leong et al.   WORLD JOURNAL OF SURGERY

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

(2009) Yeon Hee Park et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

(2009) Carol A. Parise et al.   Breast Journal

Clinical Relevance ofHER2Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer

(2009) Giuseppe Curigliano et al.   JOURNAL OF CLINICAL ONCOLOGY

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

(2009) Ana M. Gonzalez-Angulo et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

(2009) Heikki Joensuu et al.   JOURNAL OF CLINICAL ONCOLOGY

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY